Journal of Diabetes and Its Complications
Volume 20, Issue 3 , Pages 163-169 , May 2006

Major complications have an impact on total annual medical cost of diabetes: Results of a database analysis

  • Andrea Morsanutto

      Affiliations

    • Centro di Farmacoeconomia, Università degli Studi di Milano, Milano, Italy
    • ,
  • Patrizia Berto

      Affiliations

    • PBE Consulting, Verona, Italy
    • ,
  • Stefania Lopatriello

      Affiliations

    • PBE Consulting, Verona, Italy
    • ,
  • Renzo Gelisio

      Affiliations

    • Centro Antidiabetico, ULSS Portogruarese, Portogruaro (VE), Italy
    • ,
  • Dario Voinovich

      Affiliations

    • Università degli Studi di Trieste, Trieste, Italy
    • ,
  • Paola Perelli Cippo

      Affiliations

    • Centro di Farmacoeconomia, Università degli Studi di Milano, Milano, Italy
    • ,
  • Lorenzo Giovanni Mantovani

      Affiliations

    • Centro di Farmacoeconomia, Università degli Studi di Milano, Milano, Italy
    • CIRF–Center of Pharmacoeconomics, Università degli Studi di Napoli Federico II, Naples, Italy
    • Corresponding Author InformationCorresponding author. Center of Pharmacoeconomics, University of Milan, Via Balzaretti 9, I-20133 Millan, Italy. Tel: +39 (0) 2 50318256; fax: +39 (0) 2 50318255.

Received 18 January 2005 ,Revised 1 June 2005 ,Accepted 2 June 2005.

References 

  1. Brandle M, Zhou H, Smith BR, Marriott D, Burke R, Tabaei BP, et al. The direct medical cost of type 2 diabetes. Diabetes Care. 2003;26:2300–2304
  2. Brunetti P. Il Diabete Mellito e le sue complicanze; dalla diagnosi alla terapia. Milano: Editrice Kurtis; 2000;
  3. Bruno G, Rivetti M. Epidemiologia del diabete mellito. In:  Manai M editors. Aspetti attuali del diabete mellito 2002. Quartu Sant'Elena: Graf and Graf; 2002;
  4. Drummond MF, O'Brien BJ, Stoddard GL, Torrance GW. Methods for the economic evaluation of health care programmes. 2nd ed. Oxford: Oxford University Press; 1997;
  5. Garancini MP. L'epidemiologia del diabete non-insulino-dipendente e della ridotta tolleranza al glucosio. Il diabete in Italia. Milano: Editrice Kurtis; 1996;
  6. Informatore Farmaceutico, Ed. OEMF, Roma, 2002.
  7. King H, Aubert RE, Herman W. Global burden of diabetes, 1995–2025. Prevalence, numerical estimates, and projections. Diabetes Care. 1998;21:1414–1431
  8. Laboratorio di Telematica per la Salute dell'IRCCS Burlo Garofolo di Trieste. Linee Guida sul Diabete; classificazione, diagnosi, raccomandazioni. Centro Scientifico Editore. CD-ROM, 2000.
  9. Lucioni C, Garancini MP, Massi-Benedetti M, Mazzi S, Serra G. Il costo sociale del diabete di tipo 2 in Italia: Lo studio CODE-2. Pharmacoeconomics Italian Research Articles. 2000;2:1–21
  10. Massi-Benedetti M, Orsini–Federici M. Organizzazione dei servizi di Diabetologia e Malattie Metaboliche. In:  Manai M editors. Aspetti attuali del diabete mellito 2002. Quartu Sant'Elena: Graf and Graf; 2002;
  11. Ministero della Salute . www.ministerodellasalute.it/medicinali/bancadati[accesso del 13 e 14 novembre 2002]
  12. Ministero della Sanità. Nomenclatore Tariffario delle prestazioni ambulatoriali DM7.22.7.96; Gazzetta Ufficiale n° 216, 14.9.96
  13. Ministero della Sanità. Aggiornamento delle tariffe delle prestazioni di assistenza ospedaliera di cui al DM 14.12.1994; DM 30.6.97 SO GU n°209 8.9.1997
  14. UK Prospective Diabetes Study Group . Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes. Lancet. 1998;352:837–853
  15. UK Prospective Diabetes Study Group . Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36). British Medical Journal. 2000;321:412–419
  16. UK Prospective Diabetes Study Group . The UKPDS risk engine: A model for the risk of coronary heart disease in type 2 diabetes (UKPDS 56). Clinical Science. 2001;101:671–679
  17. World Health Organisation . Guidelines for the development of a national programme for diabetes mellitus. Geneva: WHO Division of Noncommunicable Disease and Health Technology; 1991;
  18. Zoppini G, Verlato G, Bonora E, Muggeo M. Attending the diabetes center is associated with reduced cardiovascular mortality in type 2 diabetic patients: The Verona Diabetes Study. Diabetes/Metabolism Research and Reviews. 1999;15:170–174

 This study was not financially supported.

PII: S1056-8727(05)00080-2

doi: 10.1016/j.jdiacomp.2005.06.011

Journal of Diabetes and Its Complications
Volume 20, Issue 3 , Pages 163-169 , May 2006

Article Tools

* Image Usage & Resolution